Friday - April 4, 2025
University of Texas's El Paso: Common Malaria Drug Repurposed to Fight Cancer
March 04, 2025
EL PASO, Texas, March 4 -- The University of Texas's El Paso campus issued the following news release:

* * *

Common Malaria Drug Repurposed to Fight Cancer

UTEP researchers secure patent for pyronaridine, drug that shows promise for killing cancer cells

EL PASO, Texas (March 3, 2025) - Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products